The anti-diabetic drug rosiglitazone has previously been reported to be associated with heart attack and death. A new study revealed that it also causes a high risk of bone fracture due to high fat deposits from the blood to the bone.
The anti-diabetic drug rosiglitazone has previously been reported to be associated with heart attack and death. A new study revealed that it also causes a high risk of bone fracture due to high fat deposits from the blood to the bone.
Share this Article
Recommended